Advertisement
Home »

Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety.

Jan 01, 2024

ABOUT THE EXPERTS

  • M T Corasaniti

    Department of Health Sciences, University “Magna Graecia” of Catanzaro, Catanzaro, Italy.

    G W Lawrence

    Department of Biotechnology, Dublin City University, Dublin, Ireland.

    G Bagetta

    Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

    R Iannacchero

    Department of Neurology, Headache Center, Regional Hospital “Pugliese-Ciaccio”, Catanzaro, Italy.

    A Tarsitano

    Pain Therapy Center, Provincial Health Authority (ASP), Cosenza, Italy.

    A Monteleone

    Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

    M Pagliaro

    Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

    P Tonin

    Regional Center for Serious Brain Injuries, S. Anna Institute, Crotone, Italy.

    G Sandrini

    Department of Brain and Behavioral Sciences, IRCCS C. Mondino Foundation Neurologic Institute, University of Pavia, Pavia, Italy.

    P Nicotera

    German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

    D Scuteri

    Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

    Regional Center for Serious Brain Injuries, S. Anna Institute, Crotone, Italy.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement